GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Alembic Pharmaceuticals Ltd

Alembic Pharma Board Meeting to Approve Q1 FY27 Unaudited Financial Results

RESULTS ● No Immediate Change LOW RISK
📅 Filed on BSE: 24 Jul 2026, 05:58 PM IST  ·  BSE ID: 26893955-0db5-40a4-9472-106ef4e2c617
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board will meet on August 4, 2026, to review and approve its financial results for the April-June quarter.
🤖 AI Summary
  • Alembic Pharmaceuticals Ltd Board meeting scheduled for Tuesday, August 4, 2026.
  • Meeting agenda includes considering and approving Unaudited Financial Results for the quarter ended June 30, 2026.
  • The trading window for company securities closed on July 1, 2026.
  • Trading window will re-open 48 hours following the declaration of the financial results.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders based on this announcement.
👤
Who Is Affected
All shareholders are indirectly affected as this meeting will determine the first quarter (Q1 FY27) financial performance to be subsequently released to the public.
🔍
Management Signal
Management is adhering to regulatory timelines for disclosing quarterly financial results and maintaining compliance with trading window regulations.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Declaration of Unaudited Financial Results for the quarter ended June 30, 2026.
Specific details regarding revenue and profit in the upcoming Q1 FY27 results.
LOW RISK This filing is a routine board meeting announcement with no immediate new risks identified.
💡 Investor Takeaway
Alembic Pharmaceuticals Ltd has scheduled a Board Meeting for August 4, 2026, to approve its Unaudited Financial Results for the quarter ended June 30, 2026. This is a standard corporate governance announcement ahead of financial reporting.
❓ Frequently Asked Questions
When is the Board Meeting for Alembic Pharmaceuticals Ltd scheduled?
The Board Meeting for Alembic Pharmaceuticals Ltd is scheduled for Tuesday, August 4, 2026.
What is the purpose of Alembic Pharmaceuticals Ltd's upcoming Board Meeting?
The purpose of the upcoming Board Meeting is to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2026.
When will the trading window re-open for Alembic Pharmaceuticals Ltd securities?
The trading window for Alembic Pharmaceuticals Ltd securities, which closed on July 1, 2026, will re-open 48 hours after the declaration of the financial results.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.